Duloxetine HCl

Duloxetine HCl


Negotiable Min Order Quantity Unit

Required Quantity
Place of Origin
South Korea
Payment Terms
Negotiable
Production method
Negotiable
Shipping / Lead Time
Negotiable / Negotiable
Keyword
active pharmaceutical ingredient, api, duloxetiine hcl
Category
Other Pharmaceuticals

Inist ST

Membership
VIP
Country / Year Established
South Korea South Korea / 2000
Business type
Manufacturer
Verified Certificate

16

TRADE TOWER

DUNS

Product name Duloxetine HCl Certification -
Category Other Pharmaceuticals Ingredients -
Keyword active pharmaceutical ingredient , api , duloxetiine hcl Unit Size -
Brand name - Unit Weigh -
origin South Korea Stock -
Supply type - HS code -

Product Information

| Category |

 

Antidepressants

 

| Spec |

 

JP / IHS

 

| Description |

 

Duloxetine is a dual serotonin and norepinephrine reuptake inhibitor. It was originally discovered in 1993 and developed by Eli Lilly and Company as LY248686. Duloxetine first received approval from the FDA in August, 2004 as Cymbalta for the treatment of Major Depressive Disorder. It has since received approval for a variety of indications including the treatment of neuropathic pain, Generalized Anxiety disorder, osteoarthritis, and stress incontinence. Duloxetine continues to be investigated for the treatment of pain in cancer, surgery, and more.

 

 

 

B2B Trade

Price (FOB) Negotiable transportation -
MOQ Negotiable Leadtime Negotiable
Payment Options Negotiable Shipping time Negotiable

Inist ST

Country / Year Established
South Korea South Korea / 2000
Membership
VIP
Business type
Manufacturer

16

TRADE TOWER

DUNS

President
Kim Kuk-hyun
Address
Geumwang-Eup, 500 Shinaero , Eumseong-gun, Chungcheongbuk-do, Korea
Product Category
Pharmaceuticals
Year Established
2000
Company introduction

Having persistent enthusiasm, INIST ST is trying to contribute to the society and community by delivering healthier life from age 0 to 110 years through research and innovation. Since its establishment in 2000, INIST ST has been accomplishing rapid growth with passion, confidence and trust between customers and the company. INIST ST has developed non-cytotoxic anti-cancer, high quality generic & value-added API and supplied to the domestic and overseas markets. INIST ST has intensive R&D function in exploration of drug candidate and process development of small molecules. As result of those efforts, INIST ST has achieved multiple crystal and process patents and become partner of several government sponsoring development projects.

Main Markets

Japan Japan

Taiwan Taiwan

Turkey Turkey

U.S.A U.S.A

Main Product

Related Products

Other buyers also search

Membership Grade

BUYER

Biz Pro VIP

SELLER

Biz Pro VIP
팝업닫기
Live Chat A new message arrives
from a business partner.

No Data

  • There is no data to load
  • Check out the My TK > My Inquiries list.
  • After agreeing to the use of the Live Chat service, the list is printed only when there is at least one history of receiving or sending a Live Chat request.

If you have not yet agreed to use the Live Chat service,

You can use the Live Chat freely after agreeing to the use of the Live Chat service.

View more
View more